Clinical Trial Update: Study to Evaluate the Effectiveness of Legalon®

View source ↗

Summary

A completed clinical trial sponsored by Mylan Inc. evaluating the effectiveness of Legalon® for non-alcoholic fatty liver disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Fatty Liver Disease

Drugs mentioned

• Legalon (silymarin)

Snippet

Sponsor: Mylan Inc. | Conditions: Non-alcoholic Fatty Liver Disease (NAFLD) | Status: COMPLETED